These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Research and standardization in Alzheimer's trials: reaching international consensus. Carrillo MC; Rowe CC; Szoeke C; Masters CL; Ames D; O'Meara T; Macaulay SL; Milner A; Ellis KA; Maruff P; Rainey-Smith SR; Martins RN; Bain LJ; Head RJ; Alzheimers Dement; 2013 Mar; 9(2):160-8. PubMed ID: 23266004 [TBL] [Abstract][Full Text] [Related]
27. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
28. Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives. Wang J; Tan L; Yu JT J Alzheimers Dis; 2016; 50(4):927-45. PubMed ID: 26836177 [TBL] [Abstract][Full Text] [Related]
29. Ocular biomarkers for early detection of Alzheimer's disease. Frost S; Martins RN; Kanagasingam Y J Alzheimers Dis; 2010; 22(1):1-16. PubMed ID: 20847434 [TBL] [Abstract][Full Text] [Related]
30. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues. Gauthier S; Leuzy A; Racine E; Rosa-Neto P Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568 [TBL] [Abstract][Full Text] [Related]
31. The biomarker and therapeutic potential of miRNA in Alzheimer's disease. Bekris LM; Leverenz JB Neurodegener Dis Manag; 2015; 5(1):61-74. PubMed ID: 25711455 [TBL] [Abstract][Full Text] [Related]
32. MRI and CSF studies in the early diagnosis of Alzheimer's disease. de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364 [TBL] [Abstract][Full Text] [Related]
33. Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools. Di Carlo M; Giacomazza D; San Biagio PL J Phys Condens Matter; 2012 Jun; 24(24):244102. PubMed ID: 22595372 [TBL] [Abstract][Full Text] [Related]
34. Problems associated with biological markers of Alzheimer's disease. Frey HJ; Mattila KM; Korolainen MA; Pirttilä T Neurochem Res; 2005 Dec; 30(12):1501-10. PubMed ID: 16362769 [TBL] [Abstract][Full Text] [Related]
35. Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Gibson GE; Huang HM Front Biosci; 2002 Apr; 7():d1007-15. PubMed ID: 11897553 [TBL] [Abstract][Full Text] [Related]
36. Early detection of Alzheimer disease: methods, markers, and misgivings. Green RC; Clarke VC; Thompson NJ; Woodard JL; Letz R Alzheimer Dis Assoc Disord; 1997; 11 Suppl 5():S1-5; discussion S37-9. PubMed ID: 9348421 [TBL] [Abstract][Full Text] [Related]
37. Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Frank RA; Galasko D; Hampel H; Hardy J; de Leon MJ; Mehta PD; Rogers J; Siemers E; Trojanowski JQ; Neurobiol Aging; 2003; 24(4):521-36. PubMed ID: 12714109 [No Abstract] [Full Text] [Related]
38. Biomarkers and imaging: physics and chemistry for noninvasive analyses. Moyer BR; Barrett JA Bioanalysis; 2009 May; 1(2):321-56. PubMed ID: 21083171 [TBL] [Abstract][Full Text] [Related]
39. Oxidative challenge in Alzheimer's disease: state of knowledge and future needs. Cervellati C; Wood PL; Romani A; Valacchi G; Squerzanti M; Sanz JM; Ortolani B; Zuliani G J Investig Med; 2016 Jan; 64(1):21-32. PubMed ID: 26755810 [TBL] [Abstract][Full Text] [Related]